Take
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
March 25 (Reuters) - Take Solutions Ltd TAKE.NS:
LAUNCHES AI-DRIVEN DIGITAL HEALTH PLATFORM TAKE.HEALTH
Source text: ID:nBSE3q4Q0b
Further company coverage: TAKE.NS
(([email protected];))
March 25 (Reuters) - Take Solutions Ltd TAKE.NS:
LAUNCHES AI-DRIVEN DIGITAL HEALTH PLATFORM TAKE.HEALTH
Source text: ID:nBSE3q4Q0b
Further company coverage: TAKE.NS
(([email protected];))
Feb 17 (Reuters) - Take Solutions Ltd TAKE.NS:
TO BUILD UNIFIED AI PLATFORM FOR HEALTHCARE
Source text: ID:nBSE3XvVP3
Further company coverage: TAKE.NS
(([email protected];;))
Feb 17 (Reuters) - Take Solutions Ltd TAKE.NS:
TO BUILD UNIFIED AI PLATFORM FOR HEALTHCARE
Source text: ID:nBSE3XvVP3
Further company coverage: TAKE.NS
(([email protected];;))
Feb 10 (Reuters) - Take Solutions Ltd TAKE.NS:
TAKE SOLUTIONS LTD - TO SET UP 'ONE MINUTE CLINIC' IN INDIA
Source text: ID:nBSE7mHtjh
Further company coverage: TAKE.NS
(([email protected];))
Feb 10 (Reuters) - Take Solutions Ltd TAKE.NS:
TAKE SOLUTIONS LTD - TO SET UP 'ONE MINUTE CLINIC' IN INDIA
Source text: ID:nBSE7mHtjh
Further company coverage: TAKE.NS
(([email protected];))
Dec 31 (Reuters) - Take Solutions Ltd TAKE.NS:
VEDAMIRTHAM VENKATESAN RESIGNS AS CFO
Source text: ID:nNSE3x7yK
Further company coverage: TAKE.NS
(([email protected];))
Dec 31 (Reuters) - Take Solutions Ltd TAKE.NS:
VEDAMIRTHAM VENKATESAN RESIGNS AS CFO
Source text: ID:nNSE3x7yK
Further company coverage: TAKE.NS
(([email protected];))
Sept 13 (Reuters) - Take Solutions Ltd TAKE.NS:
TAKE SOLUTIONS - APPROVED DISINVESTMENT OF 100% EQUITY STAKE OF CO IN UNIT ECRON ACUNOVA
Source text for Eikon: ID:nBSE3QfkJF
Further company coverage: TAKE.NS
(([email protected];))
Sept 13 (Reuters) - Take Solutions Ltd TAKE.NS:
TAKE SOLUTIONS - APPROVED DISINVESTMENT OF 100% EQUITY STAKE OF CO IN UNIT ECRON ACUNOVA
Source text for Eikon: ID:nBSE3QfkJF
Further company coverage: TAKE.NS
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Take do?
TAKE Ltd is a healthcare technology and life sciences company providing clinical research, regulatory, pharmacovigilance, data sciences and AI-driven healthcare solutions. It also develops preventive healthcare and digital health platforms.
Who are the competitors of Take?
Take major competitors are XT Global Infotech, Equippp SocialImpact, HCL Infosystems, Inspirisys Solutions, ABM Knowledgeware, Intense Technologies, CyberTech Sys. &Soft. Market Cap of Take is ₹307 Crs. While the median market cap of its peers are ₹392 Crs.
Is Take financially stable compared to its competitors?
Take seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Take pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Take latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Take allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Take balance sheet?
Balance sheet of Take is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Take improving?
The profit is oscillating. The profit of Take is ₹37.47 Crs for Mar 2025, -₹119.62 Crs for Mar 2024 and -₹100.27 Crs for Mar 2023
Is the debt of Take increasing or decreasing?
Yes, The net debt of Take is increasing. Latest net debt of Take is -₹0.28 Crs as of Mar-26. This is greater than Mar-25 when it was -₹6.86 Crs.
Is Take stock expensive?
Take is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Take is 28.31, while 3 year average PE is 23.45. Also latest EV/EBITDA of Take is 0.0 while 3yr average is 8.49.
Has the share price of Take grown faster than its competition?
Take has given lower returns compared to its competitors. Take has grown at ~-17.73% over the last 10yrs while peers have grown at a median rate of 7.1%
Is the promoter bullish about Take?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Take?
There is Insufficient data to gauge this.